You would think a company that has grown its revenues 273 percent since going public in 1995 would be ready for a breather, but not MiniMed Inc.

The company, which makes insulin pumps and other products for diabetics, is moving from Sylmar to a $70 million biotech center at Cal State Northridge...

Join our Membership to get the full story.


Are you a current Member? Sign In